fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Hormone-depleting drug appears to have efficacy in localized high-risk prostate tumors

Written by | 31 Jul 2012

by Bruce Sylvester – Emerging uses of FDA Approved Drugs – A hormone-depleting drug approved in 2011 for the treatment of metastatic prostate cancer appears to help eliminate… read more.

ESMO 2011 Report – New opportunity for pain control in metastatic carcinoma of the prostate

Written by | 16 Apr 2012

by Dr Sunil Upadhyay – Prostate cancer is one of the leading causes of death due to cancer in men all over the world. Most of the prostate… read more.

ESMO 2011 Report – Radium-223 chloride in bone metastasis

Written by | 16 Apr 2012

by Dr Sunil Upadhyay – Despite encouraging progress in the early diagnosis and better management outcome of common cancers, a high proportion of patients still present with advanced… read more.

More people get cancer, yet fewer die

Written by | 16 Mar 2012

World Health Matters – Australia – by Gary Finnegan – Over the past quarter century in Australia, cancer incidence rates have increased while deaths from cancer have steadily… read more.

Public consultation on cancer medicines

Written by | 16 Mar 2012

EMA Highlights by Gary Finnegan – The EMA has launched a public consultation on its revised guidelines covering how potential cancer drugs are assessed.  The document provides guidance… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.